Tag Archives: Accredo

Cigna Launches Pathwell Specialty to Better Manage Commercial Specialty Drug Costs

Cigna recently launched Cigna Pathwell Specialty to offer access to a specialty pharmacy network for infusion and infection drugs, which is designed to be national and cost-effective

Specialty Pharmacy Services a Focus of Kaiser Permanente-Evernorth Collaboration

In the area of specialty pharmacy services, the Kaiser-Evernorth agreement seeks to deliver overall value and savings to Kaiser Permanente and its commercial plan members

argenx SE Selects Soleo Health as a Limited Distribution Partner for VYVGART

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART

Aetna Launches New Network to Cover New Gene Therapies for Rare Diseases

Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies

GBT’s Oxbryta® Accepted by FDA for Priority Review for Pediatric Sickle Cell Disease

The FDA has accepted for Priority Review the supplemental New Drug Application (sNDA) for voxelotor (Oxbryta®) for the treatment of sickle cell disease in patients aged 4 to 11 years

JNJ’s UPTRAVI (selexipag) Receives FDA Approval for Intravenous Use in Adults

The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy

Evrysdi’s Positive News Beneficial to Both Genentech and PTC Therapeutics

Accredo is the only specialty pharmacy (SP) that prepares and ships Evrysdi directly to patients each month. Evrysdi is not available at retail pharmacies

Eton Pharmaceuticals’ ALKINDI® SPRINKLE is available exclusively through AnovoRx

AnovoRx’s focus is intentionally centered on the unique needs of patients with chronic diseases who rely on specialty and orphan drugs as well as manufacturers